Table 3 Primary and secondary outcomes
Variable | HPE group n = 87 | Control group n = 94 | P value |
|---|---|---|---|
PCS score, Median (IQR) | |||
3 months | 24.40 (0.00–49.12) | 0.00 (0.00–37.0) | 0,01 |
6 months | 33.63 (0.00–71.61) | 0.00 (0.00–55.1) | 0,01 |
ICU-acquired weakness n (%) | 16 (29.1) | 26 (46.4%) | 0.05 |
Length of stay, days | |||
Median (IQR) | |||
ICU | 18 (12–36) | 23 (16–36) | 0,11 |
Hospital | 38 (18–70) | 40 (21–60) | 0,96 |
Duration of MV, days | |||
Median (IQR) | 10 (5–19) | 12 (7–21) | 0,09 |
Mortality | |||
n (%) | |||
ICU | 23 (26.4) | 41 (43.6) | 0,01 |
Hospital | 25 (31.2) | 47 (53.4) | 0,002 |
6-months follow-up | 29 (33.3) | 51 (54.2) | 0.005 |